Reappraisal of OMERACT 8 Draft Validation Criteria for a Soluble Biomarker Reflecting Structural Damage Endpoints in Rheumatoid Arthritis, Psoriatic Arthritis, and Spondyloarthritis: The OMERACT 9 v2 Criteria

W.P. Maksymowych, RB Landewe, PP Tak, C.J. Ritchlin, M Ostergaard, P. Mease, H. El-Gabalawy, P. Garnero, D.D. Gladman, O. Fitzgerald, D. Aletaha, V.P. Bykerk, J.M. Bathon, S.W. Syversen, M. Boers, PP Geusens, R.D. Inman, V.B. Kraus, TH Kvien, W.R. TaylorG.A. Wells, D.M. Van der Heijde

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1785-1791
JournalJournal of Rheumatology
Volume36
Issue number8
DOIs
Publication statusPublished - 2009

Cite this